| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: James D. Fry, University of Rochester, Rochester, NY 14627-0211., jfry{at}mail.rochester.edu (E-mail)
Communicating editor: R. G. SHAW
| ABSTRACT |
|---|
The genomic rate of mildly deleterious mutations (U) figures prominently in much evolutionary and ecological theory. In Drosophila melanogaster, estimates of U have varied widely, from <0.1 to nearly 1 per zygote. The source of this variation is unknown, but could include differences in the conditions used for assaying fitness traits. We examined how assay conditions affect estimates of the rates and effects of viability-depressing mutations in two sets of lines with accumulated spontaneous mutations on the second chromosome. In each set, the among-line variance in egg-to-adult viability was significantly greater when viability was assayed using a high parental density than when it was assayed using a low density. In contrast, the proportional decline in viability due to new mutations did not differ between densities. Two other manipulations, lowering the temperature and adding ethanol to the medium, had no significant effects on either the mean decline or among-line variance. Cross-environment genetic correlations in viability were generally close to one, implying that most mutations reduced viability in all environments. Using data from the low-density, lower-bound estimates of U approached the classic, high values of Mukai and Ohnishi; at the high density, U estimates were similar to recently reported low values. The difference in estimated mutation rates, taken at face value, would imply that many mutations affected fitness at low density but not at high density, but this is shown to be incompatible with the observed high cross-environment correlations. Possible reasons for this discrepancy are discussed. Regardless of the interpretation, the results show that assay conditions can have a large effect on estimates of mutational parameters for fitness traits.
THE genomic rate and distribution of effects of deleterious mutations are critical parameters in much evolutionary theory (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Several experiments have been performed to attempt to put a lower bound on the rate of mutations with negative effects on egg-to-adult viability in Drosophila melanogaster (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
0.1 would not. Thus the Drosophila data are frustratingly ambiguous on the evolutionary significance of deleterious mutation.
One problem with interpreting the Drosophila data is that the experiments have differed in several ways that could potentially affect the estimates: These include the method for accumulating mutations, the method for estimating base population (control) fitness, the fitness traits assayed, and the assay conditions (medium recipe, humidity, larval density, etc.). Coming to any generalizations about genomic mutation rates in Drosophila will be difficult without understanding how these factors may influence the estimates.
The goal of this study is to examine how differences in assay conditions affect estimates of the rates and effects of deleterious mutations in D. melanogaster. This was also one of the goals of our earlier study (![]()
![]()
![]()
The most widespread method for estimating the genomic rate of deleterious mutations, U, is by the formula of ![]()
![]()
![]() |
(1) |
Here,
M is the per generation rate by which fitness declines in a set of MA lines, and
V is the increase in among-line variance per generation; the "c" scales the estimate to the entire genome. Effects of assay conditions on UBM could arise through effects on
M,
V, or both. Because statistical comparisons of
M and
V between treatments are relatively straightforward, while comparisons of UBM are not, the focus of this article is on how
M and
V are affected by assay conditions.
A second goal of the work reported here is to estimate cross-environment genetic correlations in viability among the MA lines. Low correlations of mutational effects across environments would suggest the possibility that many mutations that are deleterious in some environments are approximately neutral in others. This would imply that the rate of mutations that are deleterious in at least one environment could be much higher than the rate measured in any given environment. In addition, such conditionally deleterious mutations could contribute to the evolution of specialization (![]()
![]()
![]()
![]()
![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
Mutation-accumulation experiments:
Spontaneous mutations were accumulated on D. melanogaster second chromosomes shielded from recombination and selection by the method of ![]()
![]()
![]()
100 vs. 1) and with a longer generation interval (4 weeks vs.
2.5), both of which should have slowed the accumulation of deleterious mutations relative to the MA lines. For the purpose of comparing
M between treatments, it is not necessary that the control lines accumulated no deleterious mutations, only that they accumulated fewer than the MA lines.
Viability assays:
Viability was assayed using the "Curly" method. In this method, Cy/+i females and males are intercrossed, where +i denotes a wild-type chromosome derived from the ith MA line, and Cy denotes a balancer chromosome bearing the dominant markers Curly and Rough eye (![]()
![]() |
(2) |
The 1 in the denominator is a slight bias correction (![]()
Viability assays were performed at generations (G)27 and G33 in experiment 1 and at G31 and G35 in experiment 2. In each experiment, approximately one-half the MA lines were assayed at the earlier time, and the remainder were assayed at the later time. All three control populations were assayed at both times.
Four environmental treatments were used for the viability assays. In the "standard" treatment, six pairs of Cy/+ flies were allowed to lay eggs on cornmeal-molasses-dead yeast-agar medium at 25°. Each of the other three treatments differed in one respect from the standard treatment: Two pairs were allowed to lay eggs in the "low-density" treatment; the temperature was reduced to 18° in the "low-temperature" treatment; and the medium was supplemented with 10% ethanol in the "ethanol" treatment. In the first set of assays in each experiment (G27 and G31), viability was measured in the standard, low-density, and low-temperature treatments, with 6 and 12 replicate crosses per treatment for each MA and control line, respectively. In the second set of assays (G33 and G35), viability was measured in the standard and ethanol treatments, with 8 MA and 16 control replicates. Crosses produced an average of 300 flies (range 21531), with only 1% producing <100. Additional details may be found in ![]()
The standard and low-density treatments were designed to match roughly the conditions (medium, temperature, and parental density) used by ![]()
![]()
![]()
![]()
![]()
Lines classified as lethal (<5% relative viability) on the basis of the first two crosses in the standard treatment were not considered further. Lethal mutation rates were 1.0% per generation (95% C.I.: 0.71.5%) in experiment 1 (![]()
After each set of viability assays, each control population and 510 of the assayed MA lines were checked for contamination by scoring polytene second chromosomes for insertion sites of the transposable elements roo [experiment (exp.) 1] or copia (exp. 2). All lines in exp. 1 shared a common set of 19 roo sites (![]()
![]()
Statistical analysis:
Means, among-line, and within-line variances, as well as standard errors for these statistics, were estimated for each treatment and line type (MA or control) separately by restricted maximum likelihood (REML), using the MIXED procedure in SAS version 8 (SAS INSTITUTE 1992; ![]()
![]()
Likelihood-ratio tests were also used to determine whether
V differed among treatments, using data for each treatment pair within each set of MA lines. In the full model, among-line variances were allowed to differ between treatments ("unstructured" covariance option on "RANDOM" statement); in the constrained model, the variances were constrained to be equal ("Toeplitz" covariance option). Both the constrained and unconstrained models allowed residual variances to differ between treatments ("GROUP =" option on "RESIDUAL" statement) and included random block and block x treatment interactions. The test in this case is two-tailed. Because comparisons of variances are likely to be sensitive to violations of the normality assumption, the comparisons were done only for "quasinormal" lines. These are defined as lines with more than one-half the viability of the controls (cf. ![]()
![]()
![]()
Genetic correlations across treatments and their standard errors were estimated by repeating the above unconstrained analyses using the "UNR" covariance option. Likelihood-ratio tests of the hypotheses rg = 0 and rg = 1 were performed by constraining the correlations with the "UN(1)" covariance option and the "PARMS" statement, respectively. The test of rg = 0 is two-tailed, while that of rg = 1 is one-tailed. If the point estimate of rg was 1, no standard error could be calculated; instead, a lower bound for rg was found as the smallest value that did not cause a significant (P < 0.05) increase in the log-likelihood of the model.
To determine whether
M differed among treatments, PROC MIXED was used to perform an analysis on the line means, with fixed effects of line type, treatment, and their interaction. A significant interaction would imply that the difference in viability between MA lines and controls depends on treatment and hence that
M differs among treatments. (Attempts to perform a similar analysis on the raw values rather than on means were unsuccessful, due to lack of convergence and exceedingly long run times.) The analysis took into account the correlations of MA line means across treatments, using the unstructured and heterogeneous Toeplitz covariance options for datasets with two and three treatments, respectively. These covariance structures also permit variances among lines to differ between treatments. Separate covariance matrices were estimated for MA and control lines, using the GROUP = option; this allowed variances to differ between MA lines and controls. To increase the power of the analysis by eliminating extraneous parameters, correlations across treatments for the control lines were assumed to be zero, as expected if most of the variation among the controls was due to sampling error. This assumption did not significantly reduce the fit of the model (likelihood-ratio tests, P > 0.15), except in the case of the G33 dataset of experiment 1 (P < 0.01). For this dataset, results are reported with and without the correlation constrained.
Estimates of the mutational parameters
M and
V were made for each treatment in each experiment.
M was calculated as the difference in mean viability between MA lines and controls, divided by the generation number and control mean.
V was calculated as the variance among MA lines, divided by the generation number and the square of the control mean. For the standard treatment, in which viability was measured in both sets of lines in each experiment, the estimates reported are the averages of the two estimates, weighted by the number of lines in each set. UBM was calculated by Equation 1, with c = 5. The Bateman-Mukai upper-bound estimate of the average mutational effect, SBM, was calculated as the ratio of
V to
M. Both UBM and SBM were estimated with severely deleterious lines excluded; such estimates are likely to be the most informative (![]()
If a subset of MA lines had viability-increasing mutations, UBM would severely underestimate U (cf. ![]()
| RESULTS |
|---|
Mean viabilities of the MA and control lines are given in Table 1, and viabilities of the individual lines are depicted in Fig 1 and Fig 2. MA line means were always lower than control means (Table 1); in the mixed-model analysis, effects of line type were significant in each of the four datasets (Table 2). Treatment effects were less strong. In the first sets of assays (G27 and G31), means were lower in the standard treatment than in the low-density and low-temperature treatments (Table 1); the differences approached significance only in experiment 1, however (Table 2). In the second set of assays in experiment 1 (G33), viability was significantly or almost significantly lower in the ethanol treatment than in the standard treatment (Table 1 and Table 2). In contrast, in experiment 2 (G35), the pattern of means was reversed, but the differences were not significant. In no case was the interaction between treatment and line type significant (Table 2); thus there is no evidence that the difference in viability between control and MA lines (and hence
M) depended on treatment.
|
|
|
|
In both the G27 (exp. 1) and G31 (exp. 2) datasets, two MA lines classified as severely deleterious in the low-temperature treatment were nonetheless quasinormal in the other two treatments (Fig 1). In the G35 dataset (exp. 2) were four severely deleterious lines, two of which were severely deleterious in the ethanol treatment only (Fig 2). Excluding the severely deleterious lines had little effect on inferences about line type or treatment effects (Table 2).
Variances among the control lines were low and nonsignificant in 9 of 10 instances, the exception being the standard treatment of experiment 2 at G31 (Table 3, Fig 1 and Fig 2). The same three control lines did not differ when retested at G35 (Table 3, Fig 2), suggesting that the difference at G31 had a temporary, environmental cause. In contrast, variances among the MA lines were highly significant except in the low-density treatment, where they nonetheless approached significance (Table 3).
|
Variances among the MA lines were significantly greater in the standard treatment than in the low-density treatment in each experiment (Table 3 and Table 4). The difference was more than fivefold in each case. In experiment 2 but not experiment 1, the among-line variance in the low-temperature treatment was significantly higher than that in the low-density treatment. No other differences in among-line variances were significant. Because REML comparisons of variances are sensitive to nonnormality, we repeated the comparisons between the standard and low-density treatments using a nonparametric bootstrap procedure. Viability means were calculated for each line and treatment combination, and 10,000 bootstrap samples of the resulting bivariate distributions were made by sampling lines with replacement. For each sample, the variance of line means was calculated for each treatment. Variances in the standard treatment exceeded those in the low density treatment in all but 3.1 and 1.4% of the samples in experiments 1 and 2, respectively. This test is conservative because both among- and within-line variances contribute to the sample variance of line means, and the latter were higher in the low-density treatment (Table 3). The results thus confirm the treatment effect on among-line variances.
|
In an analysis of variance on data from the standard and low-density treatments in experiment 1, there was no significant interaction between line and treatment (Table 2 in ![]()
![]()
![]()
All cross-environment correlations in viability were positive (Table 5, Fig 1 and Fig 2). Of eight correlations estimated with severely deleterious lines excluded, four were equal to one, two were not significantly less than one (P > 0.15), and two approached being significantly less than one (P
0.06; Table 5). Inclusion of the severely deleterious lines in some cases decreased, but in others increased, the correlations.
|
With severely deleterious lines excluded, the range in
M among treatments was 0.100.37% in experiment 1 and 0.150.31% in experiment 2 (Table 6). Including the severely deleterious lines increased the estimates, although not dramatically. Differences in
M between treatments were not consistent across experiments, as expected given that they were within the bounds of sampling error (see above). Averaging across experiments,
M with severely deleterious lines excluded showed a small range among treatments, from 0.19% in the standard treatment to 0.29% in the low-temperature treatment.
|
Estimates of
V with severely deleterious lines excluded were fairly consistent between experiments (Table 7), showing less than twofold variation in each treatment. Averaging across the standard, low-temperature, and ethanol treatments,
V with severely deleterious (SD) lines excluded was
3.4 x 10-4. (For simplicity, these are referred to as the "high-density" treatments, even though larval density was not necessarily higher in the latter two treatments than in the low-density treatment; see MATERIALS AND METHODS). Average
V in the low-density treatment was 0.55 x 10-4 (note that no lines were classified as severely deleterious in the low-density treatment). Including SD lines greatly increased the
V estimates, with the differences between the low-density treatment and the other treatments becoming larger.
|
Because
M and
V did not vary significantly among the high-density treatments, we pooled estimates of these quantities from these treatments to estimate UBM and SBM. Using the
M values in Table 6 for quasinormal lines, the weighted average from the high-density treatments is 0.210% in experiment 1 and 0.254% in experiment 2. Combining these with the above
V values (using c = 5 in Equation 1) gives UBM = 0.071 and SBM = 0.148 for experiment 1 and UBM = 0.088 and SBM = 0.145 for experiment 2. These mutation rate estimates are similar to those reported by ![]()
![]()
![]()
![]()
![]()
To test whether some MA lines had viability-increasing mutations, which would cause UBM to severely underestimate U, means of each MA line in each treatment were contrasted to that of the pooled controls. The lack of significant variation among the control lines in most instances (Table 3) justified pooling them; in the one case where significant variation among the controls was present, the comparisons are liberal. No MA line had viability significantly higher than that of the controls (P < 0.05) after adjusting for multiple comparisons. In contrast, an average of four (range 08) quasinormal lines had viability significantly lower than that of the controls in the 10 datasets.
| DISCUSSION |
|---|
In this study, the mutational variance for viability was strongly affected by the parental density of the viability assays in each of two MA experiments, being sevenfold higher in the higher-density standard treatment than in the low-density treatment. In contrast, the rate of mutational decline was unaffected by density, within the limits of detection. Two other environmental manipulations, reducing the temperature and adding ethanol to the medium, had no effect on either the mutational variance or mean decline, after a small number of lines with severely deleterious mutations were excluded.
Our previous lower-bound estimate of the rate of deleterious mutations in experiment 1 was UBM = 0.105 (![]()
![]()
![]()
![]()
![]()
Our results suggest that the variation among Drosophila studies in estimates of mutational parameters for viability could have been caused partly by differences in assay density. A review of
V estimates from studies that used the Curly method for estimating viability gives some support for this conclusion (Table 8; see Appendix). The estimates from the four studies that used a relatively high density vary widely, from 0.69 to 3.97 x 10-4, and overlap those from the two studies using a lower density (0.550.83). Among the high-density studies, however, is that of ![]()
V estimate. For example, there is evidence that an appreciable fraction of the mildly deleterious mutations detectable in two Drosophila MA experiments (including exp. 1 here but not exp. 2) was caused by movement of the retrotransposable element copia (S. V. NUZHDIN, D. HOULE and J. D. FRY, unpublished data). Because copia transposes only in males (![]()
V estimated from full-sib MA lines, in which genes spend one-half their time in females, might be expected to be lower than that estimated from Mukai-type lines, in which second chromosomes are passed exclusively through males. With the ![]()
![]()
![]()
![]()
|
On the other hand, density variation did not significantly affect
M in this study, and much of the variation in UBM estimates is due to differences in
M estimates (e.g., ![]()
![]()
![]()
M estimates of ![]()
![]()
![]()
![]()
![]()
All conclusions about
M in this study, and hence about UBM and SBM, are subject to the caveat that they depend on the validity of the control populations. If the control populations had accumulated adaptive or deleterious mutations,
M would have been overestimated or underestimated, respectively. Adaptive mutations would have had to have large effects to reach high frequencies in the 1726 generations that elapsed between when the control lines were established and when the viability assays were performed. It seems unlikely that large-effect adaptive mutations would have arisen and escaped stochastic loss in the first few generations in all three control lines; adaptive mutations in one or two lines only would have caused divergence between the lines in viability, which was not observed. Some decline in control viability due to deleterious mutations could have occurred, but if the declines were approximately equal in the different treatments, they would not have affected the conclusions about treatment effects on
M. One could hypothesize that, because the control populations were maintained at 18° (![]()
M estimates at 25° downward. Such mutations do not appear to occur at a high rate, however (Fig 1). ![]()
Cross-environment correlations of viability were generally close to one. Our results therefore do not support the conclusion that there is a high rate of mutations with conditionally deleterious effects, as required by some models of the evolution of ecological specialization (![]()
![]()
![]()
Does density affect U?:
Having two sets of estimates of UBM, one for each density, raises the question of which set is to be preferred when drawing conclusions about the evolutionary impact of deleterious mutations. We consider three possible interpretations of the disparate estimates. The interpretations are based on the well-known relationships (e.g., ![]()
M and
V and the underlying parameters U,
and
2s, where the latter two parameters are the mean and variance, respectively, of mutational effects,
![]() |
(2a) |
and
![]() |
(2b) |
Here, C is the coefficient of variation of mutational effects
s/
.
The first possibility is that the point estimates of UBM and SBM are correct for all practical purposes. This requires that mutations had constant effects (C = 0) within a given environment; otherwise, UBM will underestimate U, and SBM will overestimate
. The problem with this hypothesis is that it is not possible to reconcile the large difference in mutation rates between environments implied by the UBM estimates with the observed high cross-environment correlations for viability (Table 5). If Ui and si are rates and effects of mutations as measured in environment i (1 = low density, 2 = high density), then the highest cross-environment correlation occurs when the mutations that affect viability in the high-density treatment are a subset of those that affect viability in the low-density treatment. In this case, U2 is the rate of mutations with effects in both treatments, while U1 - U2 is the rate of mutations that affect viability only in the low-density treatment. The cross-environment covariance among MA lines is then U2s1s2, and the cross-environment correlation is
![]() |
(3) |
For experiment 1, the predicted rg is 0.31, well below the lower bound of 0.79 for rg between the low-density and standard treatments (Table 5). For experiment 2, the predicted correlation is 0.65, which is above the lower bound for rg between the low-density and standard treatments, but below that between the low-density and low-temperature treatments (Table 5).
A second possibility is that the point estimates of
M and
V are accurate, but that mutation effects were not constant, leading to underestimation of U and overestimation of
at one or both densities. To see whether this hypothesis can be reconciled with the high cross-environment correlations, we make the nonrestrictive assumption that U is the same between densities; if a subset of mutations has no effect at one density, this can be reflected in lower
and higher C. The cross-environment correlation can be derived by considering an expression analogous to (2b) for the mutational covariance across environments. After some rearrangement, we obtain
![]() |
(4) |
Here, rm is the cross-environment correlation of effects of individual mutations. The mutational variances provide information on C1 and C2. Under the assumption that there was no difference in
M between densities,
at the different densities must have been equal (by Equation 2a); it follows that any differences in
V were due to differences in C (Equation 2b). Specifically, the ratio
V2/
V1 is given by
. Values of this ratio from Table 7 (5.3 for experiment 1, 7.2 for experiment 2) can be used to give an expression for C2 in terms of C1. After substituting this into Equation 4 and taking rm = 1, we solved numerically for the minimum value of C1 consistent with the lower bounds for rg from Table 5 (0.79 for experiment 1, 0.74 for experiment 2). This gives C1 = 0.58 and 0.55 for the two experiments. Because UBM estimates U/(1 + C2), under this model U in the low-density treatment would have to be higher than the estimated UBM values; the corrected U values are 0.96 and 0.27 in experiments 1 and 2, respectively. These are also estimates of U in the high-density treatments under this model; the great disparity between U and UBM for these treatments results from the high values of C2 implied by the ratio
V2/
V1.
Equation 4 generalizes Equation 7 of ![]()
![]()
![]() |
(5) |
When rm < r*m, rg > rm, but when rm > r*m, rg < rm. Note that if C1 = C2,
, so rg will never be <rm. When C1 and C2 are very unequal, however, it is possible for rg to be << rm. An intuitive explanation for this is that, if C2 >> C1
0, much of the variance among MA lines in environment 2, but not environment 1, will be due to variation in mutational effects (see Equation 2b). This component of variation in environment 2 will be only weakly correlated with variation in environment 1, which will be caused mostly by variation in the numbers of mutations carried by the different MA lines.
A third possibility is that
M and/or
V were estimated with substantial error, in such a way as to inflate the differences in UBM and SBM between treatments. The
V estimates seem fairly robust; they were consistent between experiments (Table 7), and the estimates for the standard treatment reported here are quite similar to estimates calculated for the same lines using the covariance between viabilities of lines at widely separated times (![]()
M estimates were less consistent between experiments (Table 6) and were based on only three control populations. The weakest link may be the
M estimates in the low-density treatment, which were based on smaller datasets than those from the standard or combined high-density treatments. Overestimation of
M may have contributed to the surprisingly high UBM estimate for the low-density treatment of experiment 1.
In summary, if the estimates of
M and
V are assumed to be accurate, the results support the high estimates of deleterious mutation rates of Mukai and Ohnishi. An alternative possibility, more consistent with the conclusions of ![]()
Previous work on genotype x environment interaction from new mutations:
Genotype x environment interaction for fitness from new mutations has been investigated in several previous studies, of Drosophila and other organisms. The limited data give no support for a general effect of density on
V, but indicate that other types of environmental stress can sometimes increase
V estimates.
![]()
V, but imply that
M increases with density, contrary to the results reported here. There are at least two possible explanations for this difference in results. The range of densities used by Kondrashov and Houle was 16-fold, compared to only 3-fold in this study, giving them greater power to detect density effects on
M. Furthermore, the MA lines had accumulated mutations for about twice as long as in the current study, again probably resulting in greater power.
Studying D. melanogaster, ![]()
V for a fitness measure that integrated viability and fertility. Mean-standardized
V was greater when assays were performed at low temperature, but this was because of lower mean performance at the low temperature, rather than an increase in the among-line variance. Because the MA lines had a population size of 10 pairs, selection is likely to have played a much more important role in filtering new mutations in this experiment than in most MA experiments.
![]()
![]()
V to be higher in the environments with lower means (high salt, dilute food). ![]()
![]()
![]()
M and
V were similar between the competitive and noncompetitive datasets, giving no support for a general effect of density on
V. Nonetheless, it is possible that their results would have been different had they assayed MA lines simultaneously in the different treatments, particularly since many of the lines assayed by ![]()
![]()
![]()
![]()
M for the intrinsic rate of increase was almost 2-fold higher at the stressful temperature, and
V was >25-fold higher. As a result of the proportionately much larger increase of
V, UBM was lower at the more stressful temperature, and SBM was higher. These results thus parallel the results reported here, except that we observed no treatment effects on
M.
![]()
![]()
![]()
0.1) are likely to be greatly underrepresented at the end of such an exponential growth phase. In ![]()
![]()
Only three of the above studies have reported cross-environment genetic correlations among the MA lines. In the studies of ![]()
![]()
| CONCLUSION |
|---|
The results reported here, as well as those of ![]()
![]()
![]()
![]()
![]()
![]()
Our results indicate that future MA experiments will be most informative when fitness traits are assayed in multiple environments. Proper design and analysis of such experiments is essential. Comparisons of mutational parameters between treatments are most meaningful when MA lines are assayed simultaneously in the different treatments. As the experience here shows, when cross-environment correlations are close to one, biologically significant differences in among-line variances may be present without giving rise to a significant genotype x environment interaction term in an analysis of variance. Likelihood methods or the bootstrap are therefore needed for comparing mutational variances between treatments.
| ACKNOWLEDGMENTS |
|---|
We thank S. V. Nuzhdin for the polytene analysis and S. Durham and R. Miller for their SAS insights. R. Shaw and two anonymous reviewers made helpful comments on an earlier draft. This work was supported by National Science Foundation grants DEB-9317754 and DEB-9707470.
Manuscript received October 17, 2001; Accepted for publication March 29, 2002.
| APPENDIX |
|---|
There are at least two problems in comparing
V estimates among the Drosophila second chromosome MA studies.
First, two measures of viability have been used, either relative viability as given by Equation 2 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
for the first chromosome and 1/3 = 0.333 for the second chromosome. The ratio of these two proportions is
0.86, giving the first chromosome higher relative fitness than it should have. Because the percentage of wild-type flies leads to underestimation of
V, the estimates presented by ![]()
![]()
A second problem is that the various authors have not been consistent in the practice of standardizing
V estimates by the mean viability. We have standardized our
V estimates by the mean of the controls (![]()
![]()
![]()
V estimates to be standardized by the mean of the MA lines (see below). Finally, the other authors (![]()
![]()
![]()
V estimates at all.
Using data available in the previous articles, we recalculated
V for relative viability, standardizing by the control mean, as described here.
![]()
Means and among-line variances for the proportion of wild-type flies are shown in Table A1. The means can be converted to means of relative viability by the formula
|
![]() |
(A1) |
(![]()
to express RV as an approximate linear function of %WT. Taking variances of both sides yields the relationship
![]() |
(A2) |
Applying (A2) to the datasets in this article and to OHNISHI's (1974) data (see below) shows that it tends to overestimate variances of RV by
15% (range 1118%). Consequently, to convert MUKAI's (1964) variances to the RV scale, Equation A2 was applied, and the results were divided by 1.15. While this conversion is only approximate, it is far better than no conversion, which results in
40% underestimation of
V (J. D. FRY, unpublished results).
Results of both conversions are shown in Table A1. Regressing among-line variances of relative viability against generation number, forcing the regression through the origin, gives a slope of 1.95 x 10-4. On the RV scale, the mean of the "control" lines chosen by the order method (see ![]()
.
![]()
Although ![]()
![]()
.
![]()
![]()
V estimates of 0.44, 1.18, and 4.09 (all x10-4). On the assumption that the variation among these estimates is due largely to sampling error, we have used their mean in Table 8.
![]()
These authors reported
V estimates using log-transformed relative viability. For low
V values, this transformation should give estimates similar to those from untransformed data, but standardized by the MA line mean rather than by the control mean. For higher
V values, such as those from the high-density treatments in exps. 1 and 2, it gives substantially higher estimates than do untransformed data (J. D. FRY, unpublished data). The
V estimate reported by ![]()
Another issue that affects
V estimates is the choice of threshold for declaring a line "quasinormal." ![]()
![]()
![]()
V estimates average nearly 50% lower than those in Table 6, although still more than threefold higher than those in the low-density treatment. While this would not change the major conclusions of this article, it illustrates how
V estimates can be strongly affected by seemingly minor differences in the definition of quasinormal.
| LITERATURE CITED |
|---|
BATEMAN, A. J., 1959 The viability of near-normal irradiated chromosomes. Int. J. Radiat. Biol. 1:170-180.
CHARLESWORTH, B., 1990 Mutation-selection balance and the evolutionary advantage of sex and recombination. Genet. Res. 55:199-221.[Medline]
CHARLESWORTH, B., A. LAPID, and D. CANADA, 1992 The distribution of transposable elements within and between chromosomes in a population of Drosophila melanogaster. I. Element frequencies and distribution. Genet. Res. 60:103-114.[Medline]